1. cannabis-sam
    [h2]MS drug lifts GW Pharma[/h2]
    By Neil Hume and Bryce Elder
    Published: March 12 2009 02:00

    GW pharmaceuticals rose 50 per cent to 59¾p on the back of clinical trial data that showed its lead drug, Sativex, had reduced spasticity in patients with multiple sclerosis.


    GW said it would now seek approval from European regulators for the drug. "Given the regulator has seen most of this data before, we feel the approval process should be fairly quick and GW should see the result of its application within six months post filing," Investec Securities said.


    http://www.ft.com/cms/s/0/a2ec68e0-0ea7-11de-b099-0000779fd2ac.html

Comments

  1. ConcertaXL
    it is already available in the uk.... schedule 1, but a general home office license is in operation allowing all GPs to prescribe it and all pharmacists to dispense it.
  2. old hippie 56
    Cowboy spouse has MS, and he will stand on the rooftops and proclaim that marijuana does indeed work for spasticity, anxiety, nerve pain, etc. Ya'll are lucky that your government does see the benefits of cannabis for medical conditions.
  3. old hippie 56
    Cowboy spouse has MS, and he will stand on the rooftops and proclaim that marijuana does indeed work for spasticity, anxiety, nerve pain, etc. Ya'll are lucky that your government does see the benefits of cannabis for medical conditions.
To make a comment simply sign up and become a member!